Top 5 Life Sciences Market Stories of June 2017

Top 5 Life Sciences Market Stories of June 2017

From 'Living Diagnostics' to FDA action on a painkiller drug, we look at the top stories in the life sciences market this month. Stories featured included.

-Drug maker sponsors reality TV show
-FDA asks maker to pull Opana ER due to abuse risk
-“Living Diagnostics” a possibility
-Lead test recalled due to inaccurate results
-Bristol-Myers Squibb and QIAGEN partner on NGS technology


Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

Pharma, Diagnostics and Biotech Caught in Legislative Crossfire with Release of White House Budget Blueprint

The 21st Century Cures Act was broadly supported in the U.S. Congress for its various provisions, including increased funding for cancer research and the revision of U.S. Food and Drug Administration (FDA) standards for review. The Act authorized $4.8 billion over the next 10 years for cancer research under the Moonshot Initiative, the Precision Medicine Initiative (PMI) and FDA regulatory reform. Appropriation of those funds may prove newly problematic in light of the White House administration’s disclosed budget priorities.


Cuban Biopharmaceuticals, Diagnostics and Medical Care Find Growing Interest from U.S. and International Healthcare Sectors

Cuban Biopharmaceuticals, Diagnostics and Medical Care Find Growing Interest from U.S. and International Healthcare Sectors

Remarkably, Cuba, despite near isolation from U.S. medical research, has managed notable advances in medical technology from its own industry. Cuban development of medical products such as cancer therapeutics , in vitro diagnostic (IVD) platforms and vaccines has occurred in the vacuum of U.S.-pioneered medical advances, but often manage only limited visibility internationally due to difficulties in investment. Reconciliation between the United States and Cuba has the potential to improve the di...


Will Capillary Electrophoresis Move to the Front of the Line in Top-Down Proteomics?

Will Capillary Electrophoresis Move to the Front of the Line in Top-Down Proteomics?

This blog post covers market trends in proteomics research - a field recently profiled by Kalorama Information with Proteomics Research Markets: Instruments (Mass Spectrometry, Liquid Chromatography, Electrophoresis), Disease Areas (Oncology, Cardio/Blood, Neurology, Other) Market Share and Trends. The report offers unique insight into a mass spectrometry- and analytical separation-centric life sciences market, including market shares by geography, instrument type, and vendor.

The steadily evo...


Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Gene Therapies Target an Over $100 Billion Cancer Treatment Market

Modern medicine’s more than century-long fight to treat cancer and eradicate tumors will likely benefit from a more diverse and effective arsenal in the coming years. Through a variety of routes and techniques, gene therapies are able to deliver genetic material to a specific cell population or tumor that will result in the destruction of the tumor. Gene therapies have already found clinical successes in the treatment of several non-cancer diseases, though the oncolytic or immune system-assisted...